The Walton Centre Charity Annual Report and Accounts 2021122 ol •* The Walton Centre Charity Support1119 Ix6ellen¢e Phy￿0￿¢￿￿$t Mtya In Oreor￿ patitittgyms ## ## roscic4Gc Young fundTaiserAr¢h*withdad Ad Sam Jrtel cornpletirq lus17*￿ Hope challenge mum nHi ## ## ## ## ## ## ## ## A Healthcare Assithnt pre￿￿ty a ftKX)itorto ith a patienton Chbva55eWard. ## ## ## |||||Note|2021/22|2020/21| |---|---|---|---|---|---|---| ||||||Total Funds|Total Funds| ||||||(Unrestricted)|(Unrestricted)| ||||||EOOO|E000| |Income and endowments||from;||||| |Donations
and legacies|||||257|504| |Other trading
activities|||||93|| |Investments|||||30|21| |Total income and endowments|||||380|529| |Expenditure
on:||||||| |Raising funds|||||244|194| |Chantable
activities|||||394|491| |Total expenditure|||||638|685| |Net gains/(losses)
on investments|||||86|168| |Net income/(expenditure)||and net movement|in funds|6|(172)|12| |Reconciliation
offunds:||||||| |Fund balances brought|forward||||1,561|1,850| |Fund balances carried forward|||||1,689|1,861| |||||Note|2021/22|2020/21| |---|---|---|---|---|---|---| ||||||Total Funds|Total Funds| ||||||(Unrestricted)|(Unrestricted)| ||||||EOOO|EOOO| |Fixed assets||||||| |Investments|||||1,248|1,162| |Totalfixed assets|||||1,248|1,162| |Current assets||||||| |Debtors||||||80| |Cash at bank and|in|hand|||650|680| |Total current assets|||||653|760| |Creditors
amounts||fa((ing|due within one year||212|61| |Net current assets/(liabilities)|||||441|699| |Total assets less current|||liabilities||1,689|1,861| |Total net assets|||||1,689|1,861| |Funds ofthe Charity||||||| |Unrestricted||||10|1,689|1,861| |Totalfunds|||||1,689|1,861| ## ||||Note|2021/22|2020/21| |---|---|---|---|---|---| |||||Total Funds|Total Funds| |||||(Unrestricted)|(Unrestricted)| |||||EOOO|E000| |Cash flows from operating|activities:||||| |Net cash provided
by (used in) operating||activities||(60)|(265)| |Cash flows from investing|activities:||||| |Dividends
and interest from|investments|||30|21| |Proceeds from sale of investments|||||| |Purchase of investments|||||(27)| |Net cash provided
by (used in) investing||activities||30|(6)| |Change
in cash and cash equivalents||||(30)|(271)| |in the reporting
penod|||||| |Cash and cash equwalents|at the beginning|||680|951| |ofthe reporting
penod|||||| |Cash and cash equivalents|at the end|||650|680| |ofthe reporting
period|||||| |Reconciliation
of|net income/(expenditure)|to net cash flow from operating|activities:|| |---|---|---|---|---| |Net income/(expenditure)
for the reporting||penod|(172)|12| |(as per the statement
of financia activities)||||| |Adjustments
for:||||| |(Gains)/losses
on|investments||(86)|(168)| |Dividends
and interest from investments|||(30)|(21)| |(Increase)/decrease|in debtors||77|(75)| |Increase/(decrease)|in creditors||151|(14)| |Net cash provided|by (used in) operating|activities|(60)|(265)| ## ## ## ## ## ## ## ## ## ## |||2021/22|2020/21| |---|---|---|---| |||Total Funds|Total Funds| |||(Unrestricted)|(Unrestricted)| |||EOOO|EOOO| |Income and|endowments||| |Donations||239|409| |I egaoes||18|95| |Fundraising|activities and events|93|| |Investment|income|30|21| |Total income and endowments||380|529| ||||2021/22|2020/21| |---|---|---|---|---| ||||Tota I Funds|Total Funds| ||||(Unrestricted)|(Unrestricted)| ||||EOOO|EOOO| |Raising Funds:||||| |Fundraising||staff costs|176|169| |Fundraising||activities and events|68|25| ||||244|194| |Charitable|Activities:|||| |Patients welfare and amenities|||169|199| |Staff welfare||and amenities|50|158| |Research|||127|95| |Independent||examination||| |Administrative||support|45|38| ||||394|491| |Total|||638|685| ||||2021/22|2020/21| |---|---|---|---|---| ||||Total Funds|Total Funds| ||||(Unrestricted)|(Unrestricted)| ||||EOOO|EOOO| |Fundraising|Staff Costs|||| |Salaries and|wages||142|136| |Sooal security costs|||15|15| |Employers|pension|contribution|19|19| |Total Fundraising||Staff Costs|176|170| ||||||2021/22|2020/21| |---|---|---|---|---|---|---| ||||||EOOO|EOOO| |Market value at the beginning
of the||reporting||penod|1,162|967| |Less Disposals at carrying|value|||||| |Aqutsittons
at cost||||||27| |Unreaksed
gains/(losses)|||||86|168| |Market value at the end|ofthe reporting||period||1,248|1,162| |Book cost at the end ofthe reporting||period|||1,000|1,000| |All investments
are held|in the UK and the||market value can be analysed||as follows|| ||||||2021/22|2020/21| ||||||EOOO|EOOO| |Listed investments|||||1,248|1,162| |Total|||||1,248|1,162| |||||2021/22|2020/21| |---|---|---|---|---|---| |||||EOOO|EOOO| |Prepayments|and|accrued|income||80| |Total|||||80| ||||2021/22|2020/21| |---|---|---|---|---| ||||EOOO|EOOO| |Cash|at bank and|in hand|650|680| |Total|cash and cash equivalents||650|680| |||||||2021/22|2020/21| |---|---|---|---|---|---|---|---| |||||||EOOO|EOOO| |Amounts|due|to|~HS|Foundation|Trust|23|| |Accruals||||||189|61| |Total||||||212|61| |||Balance as at|Income|Expenditure|Revaluation|of|Balance as at| |---|---|---|---|---|---|---|---| |||1April 2021|||investments||31March 2022| |||EOOO|EOOO|EOOO|EOOO||EOOO| |Unrestricted|Funds|1,693|380|(638)|||1,435| |Revaluation|Reserve|168||||86|254| |Total||1,861|380|(638)||86|1,689| |Fund|Name||||Fund Balance| |---|---|---|---|---|---| |||||2021/22|2020/21| |||||EOOO|EOOO| |4009|GeneralFund|||804|818| |4010|~RU Fund|||17|20| |4015|Wards Fund|||17|18| |4017|Roy Ferguson Compassionate||Care Fund|70|71| |4019|Headache
and Neurology|Fund|||| |4422|Pain Relief Research
Fund||||| |4442|Neuro General Research
Fund||||| |4457|Neuro Muscular
Diseases|Fund|||| |4464|Cerebro Vascular
Fund|||27|28| |4465|Home From Home||||35| |4481|Neurosurgical
General
Fund|||28|32| |4487|Horsley
ITU Fund|||76|76| |4499|Epilepsy
Fund|||27|27| |4527|RErD ft Higher Study||||20| |4528|Neurophysiology
Train
ft|Educ|||| |4530|Neurological
Disability
Fund|||65|95| |4532|L Loudrey
Mvmt Disorders|Fund|||| |4533|Alan Sutctffe Kerr Lecture|Fund|||| |4537|Cognitive
Research
Fund||||| |4538|Stereotactic
Fund||||10| |4541|Neurobiochemistry
Fund||||| |4543|Disorders Of Movement
Gen Fund|||59|60| |4550|Research
Fellowship||||| |4552|Parkinsons
Disease||||| |4900|Neuro X-Ray Research|||16|21| |4905|Neurosurgical
Neuro-Oncology|||21|30| |4910|Brain infections
Research||||| |4911|Nmo And Atypical
Disorders|||18|18| |4915|The Sid Watkins
Innovation|Fund||122|261| |||||1,438|1,693| |Fund|Fund Name||||Fund Manager|||Alms and|Obfectives||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |4009|General
Fund||||Chief Finance|Officer/Ouorum|of|Any chantable
purpose
relating toThe Walton Centre|||||||| ||||||Panel||||||||||| |4010|NRLI||||ECottier/R
Moreton|||Social and|recreational
facilities for inpatients,|||improving|||| |||||||||quality of|fife||||||| |4015|Wards Fund||||1Salter /N Martin|||Items for wards to benefit patients, carers and staff,||||||staff|study| |||||||||support|||||||| |4017|Roy Ferguson Comp Care|||Award|L Salter|||Annual compassionate
care||pro/ect|||||| |4019|~eadache And Neurology|||Fund|Dr Silver|||Research|into headache
and|allied disorders,||support|||| |||||||||presentations|||||||| |4422|Pai~ Relief Research
Fund||||Dr M Gupta/J|Tetlow||Research|and education||||||| |4442|Neuro General Research||Fund||Dr Nicolson|||Research|pro/ects
relaeng to|any|aspect ofclinical soence||||| |4457|Neuro Muscular
Diseases|||Fund|Dr C Dougan|||Research and teaching
in the||field|ofneuromuscular|||diseases|| |4464|Cerebro Vascular
Fund||||Dr Nicolson|||Research,|education,
training|and|equipment||||| |4465|~ome From Home||||Chief Finance|Officer/Ouorum|of|Maintain
the relatives' accommodation|||||||| ||||||Panel||||||||||| |4481|Neurosurgical
General|Fund|||Dr 5 Niven|||Research,|education,
training|and|equipment||||| |4487|~orsley ITIJ Fund||||Dr Lakhani/M|Rackham||Improve standard
ofcare to||patients and their relatives,|||||study| |||||||||support|||||||| |4499|Epilepsy
Fund||||Dr T Marson|||Research|||||||| |4527|RE D8~igher Study||||C Chadwick|||Research,|education,
training|and|equipment||||| |4528|Neurophysiology
Train|8||Educ|C Finnegan|||Jraining/education
for Neurophysiology
staf|||||||| |4530|Neurological
Disability|Fund|||Prof C Young|||Research/service
development
activities
in disabling|||||||| |||||||||conditions|||||||| |4533|Alan Sutcliffe Kerr Lecture|||Fund|Chief Finance|Officer||Spews list|research
and education||||||| |4537|Cognitive
Research Fund||||Dr M Doran|||Research|and development||||||| |4538|Stereotactic
Fund||||MrJ Farah|||Research|and training||||||| |4541|Neurobiochemistry
Fund||||C Chadvack/N|Moxham||Research,|education,
training|and|equipment||||| |4543|Disorders Of Movement||Gen Fund||Dr AP Moore|||Research,|education,
development
of new service initiatives||||||| |4550|Neuropsychology
Fund||||J Martlew|||Research,|patient education|and|equipment|to|||| |||||||||benefit patients|||||||| |4552|Parkinson's
Disease||||Dr M Steiger|||Research,|education
and training||||||| |4900|Neuro X-Ray Research||||Dr 5 Niven|||Advancement
of Neuroradiology|||||||| |4905|Neurosurgical
Neuro-Oncology||||Mr A Brodbelt/|Mr M Jenkinson||Research,|education,
training|and|equipment||||| |4910|Brai~ Infections Research||||Prof T Solomon|||Research|||||||| |4911|Nmo and Atypical Disorders||||Dr A Jacob|||Research|and patient care||||||| |4915|The Sid Watkins
Innovation|||Fund|Chief Finance|Officer/Quorum|of|Support
innovation
through||The|Walton Centre||in research,||| ||||||Panel|||prevention,|diagnosis,
treatment||and the overall||care of||| |||||||||people with diseases or in/ury of|||the nervous|system|||| Thank you The Charity is grateful to all our donors and supporters for all they do to raise funds an awareness for The Walton Centre Charity. to help us make a difference to patients an their families both now and in the future. A Nutse with a pawion lhel￿AYrelUrbth￿ Lipton Ward. 4 Contact us If you would like to contact us about fundraising. events or volunteering please get in touch. Call 0151556 3466 Write The Walton Centre Charity The Walton Centre NHS Foundation Trust Lower Lane, Fazakerley Liverpool L9 7LJ Visit thewaltoncentrecharity.org The Walton Centre Charity SuppDrtl&l9 Ex6¢ll¢n